Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.
about
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Phase I study of alemtuzumab f ...... nic graft-versus-host disease.
@ast
Phase I study of alemtuzumab f ...... nic graft-versus-host disease.
@en
type
label
Phase I study of alemtuzumab f ...... nic graft-versus-host disease.
@ast
Phase I study of alemtuzumab f ...... nic graft-versus-host disease.
@en
prefLabel
Phase I study of alemtuzumab f ...... nic graft-versus-host disease.
@ast
Phase I study of alemtuzumab f ...... nic graft-versus-host disease.
@en
P2093
P2860
P1476
Phase I study of alemtuzumab f ...... nic graft-versus-host disease.
@en
P2093
Bhavjot Bindra
Brett Glotzbecker
Corey S Cutler
Edwin P Alyea
Haesook T Kim
Jerome Ritz
John Koreth
Joseph H Antin
Philippe Armand
Robert J Soiffer
P2860
P304
P356
10.1016/J.BBMT.2013.02.009
P577
2013-02-14T00:00:00Z